The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Gusev E.I.

Kafedra nevrologii i neĭrokhirurgii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

Martynov M.Yu.

Kafedra nevrologii i neĭrokhirurgii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

Koltsov I.A.

Pirogov Russian National Research Medical University, Moscow, Russia

Iasamanova A.N.

Kafedra nevrologii i neĭrokhirurgii Rossiĭskogo natsional'nogo issledovatel'skogo meditsinskogo universiteta im. N.I. Pirogova

Fidler M.S.

Pirogov City Clinical Hospital, Moscow, Russia;
Pirogov Russian National Research Medical University, Moscow, Russia

Shchukin I.A.

Kafedra nevrologii i neĭrokhirurgii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

Prognostic value of endothelial dysfunction and von Willebrand factor in acute and chronic hemispheric intracerebral hemorrhage

Authors:

Gusev E.I., Martynov M.Yu., Koltsov I.A., Iasamanova A.N., Fidler M.S., Shchukin I.A.

More about the authors

Read: 2119 times


To cite this article:

Gusev EI, Martynov MYu, Koltsov IA, Iasamanova AN, Fidler MS, Shchukin IA. Prognostic value of endothelial dysfunction and von Willebrand factor in acute and chronic hemispheric intracerebral hemorrhage. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(8‑2):46‑52. (In Russ.)
https://doi.org/10.17116/jnevro201911908246

Recommended articles:
Asthenia in the acute period of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):5-10
Factors dete­rmining postoperative mortality in patients with hype­rtensive intracerebral hema­tomas. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):35-43

References:

  1. O’Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, Rangarajan S, Islam S, Pais P, McQueen MJ, Mondo C, Damasceno A, Lopez-Jaramillo P, Hankey GJ, Dans AL, Yusoff K, Truelsen T, Diener HC, Sacco RL, Ryglewicz D, Czlonkowska A, Weimar C, Wang X, Yusuf S; INTERSTROKE investigators. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376(9735):112-123. https://doi.org/10.1016/S0140-6736(10)60834-3
  2. Brandes RP. Endothelial dysfunction and hypertension. Hypertension. 2014;64(5):924-928. https://doi.org/10.1161/HYPERTENSIONAHA.114.03575
  3. Giblin JP, Hewlett LJ, Hannah MJ. Basal secretion of von Willebrand factor from human endothelial cells. Blood. 2008;112(4):957-964. https://doi.org/10.1182/blood-2007-12-130740
  4. Tsai HM, Nagel RL, Hatcher VB, Seaton AC, Sussman II. The high molecular weight form of endothelial cell von Willebrand factor is released by the regulated pathway. Br J Haematol. 1991;79(2):239-245. https://doi.org/10.1111/j.1365-2141.1991.tb04528.x
  5. Lopes da Silva M, Cutler DF. von Willebrand factor multimerization and the polarity of secretory pathways in endothelial cells. Blood. 2016;128(2):277-285. https://doi.org/10.1182/blood-2015-10-677054
  6. Dhanesha N, Prakash P, Doddapattar P, Khanna I, Pollpeter MJ, Nayak MK, Staber JM, Chauhan AK. Endothelial cell-derived von Willebrand factor is the major determinant that mediates von Willebrand factor-dependent acute ischemic stroke by promoting postischemic thrombo-inflammation. Arterioscler Thromb Vasc Biol. 2016;36(9):1829-1837. https://doi.org/10.1161/ATVBAHA.116.307660
  7. Denis CV, Lenting PJ. von Willebrand factor: at the crossroads of bleeding and thrombosis. Int J Hematol. 2012;95(4):353-361. https://doi.org/10.1007/s12185-012-1041-x
  8. Sabayan B, Westendorp RG, Grond Jv, Stott DJ, Sattar N, van Osch MJ, van Buchem MA, de Craen AJ. Markers of endothelial dysfunction and cerebral blood flow in older adults. Neurobiol Aging. 2014;35(2):373-377. https://doi.org/10.1016/j.neurobiolaging.2013.08.020
  9. Vischer UM. von Willebrand factor, endothelial dysfunction, and cardiovascular disease. J Thromb Haemost. 2006;4(6):1186-1193. https://doi.org/10.1111/j.1538-7836.2006.01949.x
  10. Lenting PJ, Casari C, Christophe OD, Denis CV. von Willebrand factor: the old, the new and the unknown. J Thromb Haemost. 2012;10(12):2428-2437. https://doi.org/10.1111/jth.12008
  11. Sadler JE. Von Willebrand factor: two sides of a coin. J Thromb Haemost. 2005;3(8):1702-1709. https://doi.org/10.1111/j.1538-7836.2005.01369.x
  12. Iida M, Nihei M, Yamazaki M, Sawaguchi M, Honjo H, Kodama I, Kamiya K. Predictive value of von Willebrand factor for adverse clinical outcome in hypertensive patients with mild-to-moderate aortic regurgitation. J Hum Hypertens. 2008;22(4):275-281. https://doi.org/10.1038/sj.jhh.1002321
  13. Xu H, Cao Y, Yang X, Cai P, Kang L, Zhu X, Luo H, Lu L, Wei L, Bai X, Zhu Y, Zhao BQ, Fan W. ADAMTS13 controls vascular remodeling by modifying vWF reactivity during stroke recovery. Blood. 2017;130(1):11-22. https://doi.org/10.1182/blood-2016-10-747089
  14. Zhu X, Cao Y, Wei L, Cai P, Xu H, Luo H, Bai X, Lu L, Liu JR, Fan W, Zhao BQ. von Willebrand factor contributes to poor outcome in a mouse model of intracerebral haemorrhage. Sci Rep. 2016;6:35901. https://doi.org/10.1038/srep35901
  15. Suslina ZA, Tanashyan MM, Domashenko MA, Ionova VG, Chechetkin AO. Disfunktsiya endoteliya pri ishemicheskih narusheniyah mozgovogo krovoobratsheniya. Annaly Klinicheskoi i Eksperimental’noi Nevrologii. 2008;2(1):4-11. (In Russ.)
  16. Prochazka V, Jonszta T, Czerny D, Krajca J, Roubec M, Macak J, Kovar P, Kovarova P, Pulcer M, Zoubkova R, Lochman I, Svachova V, Pavliska L, Vrtkova A, Kasprak D, Gumulec J, Weisel JW. The role of von Willebrand factor, ADAMTS13, and cerebral artery thrombus composition in patient outcome following mechanical thrombectomy for acute ischemic stroke. Med Sci Monit. 2018;24:3929-3945. https://doi.org/10.12659/MSM.908441
  17. Liu L, Lin Z, Shen Z. Changes of von Willebrand factor and antithrombin III levels in acute stroke: difference between thrombotic and haemorrhagic stroke. Thromb Res. 1993;72(4):353-358. https://doi.org/10.1016/0049-3848(93)90145-e
  18. Bath PMW, Blann A, Smith N, Butterworth RJ. von Willebrand factor, P-selectin and fibrinogen levels in patients with acute ischaemic and haemorrhagic stroke, and their relationship with stroke subtype and functional outcome. Platelets. 1998;9(3-4):155-159. https://doi.org/10.1080/09537109876618
  19. Horvath B, Hegedus D, Szapary L, Marton Z, Alexy T, Koltai K, Czopf L, Wittmann I, Juricskay I, Toth K, Kesmarky G. Measurement of von Willebrand factor as the marker of endothelial dysfunction in vascular diseases. Exp Clin Cardiol. 2004;9(1):31-34.
  20. Mirsaeva GKh, Khakimova RA. Endotelial’aya disfunktsiya u bol’nyh s arterial’noi gipertenziei posle perenesennogo gemorragicheskogo insulta. Klinicheskaya Laboratornaya Diagnostika. 2017;62(12):725-729. (In Russ.) https://doi.org/10.18821/0869-2084-2017-62-12-725-729
  21. Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962;194(4832):927-929. https://doi.org/10.1038/194927b0
  22. Gabbasov Z, Popov E, Gavrilov I, Pozin E. Platelet-aggregation — the use of optical-density fluctuations to study microaggregate formation in platelet suspension. Thromb Res. 1989;54(3):215-223. https://doi.org/10.1016/0049-3848(89)90229-6
  23. Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem. 1998;67:395-424. https://doi.org/10.1146/annurev.biochem.67.1.395
  24. Jy W, Jimenez JJ, Mauro LM, Horstman LL, Cheng P, Ahn ER, Bidot CJ, Ahn YS. Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation. J Thromb Haemost. 2005;3(6):1301-1308. https://doi.org/10.1111/j.1538-7836.2005.01384.x
  25. Olson J, Brockway W, Fass D, Magnuson M, Bowie E. Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet-aggregation. Am J Clin Pathol. 1975;63(2):210-218. https://doi.org/10.1093/ajcp/63.2.210
  26. Coppola R, Mari D, Lattuada A, Franceschi C. von Willebrand factor in Italian centenarians. Haematologica. 2003;88(1):39-43.
  27. Albánez S, Ogiwara K, Michels A, Hopman W, Grabell J, James P, Lillicrap D. Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms. J Thromb Haemost. 2016;14(5):953-963. https://doi.org/10.1111/jth.13294
  28. Boos CJ, Balakrishnan B, Blann AD, Lip GY. The relationship of circulating endothelial cells to plasma indices of endothelial damage/dysfunction and apoptosis in acute coronary syndromes: implications for prognosis. J Thromb Haemost. 2008;6(11):1841-1850. https://doi.org/10.1111/j.1538-7836.2008.03148.x.
  29. Tóth NK, Székely EG, Czuriga-Kovács KR, Sarkady F, Nagy O, Lánczi LI, Berényi E, Fekete K, Fekete I, Csiba L, Bagoly Z. Elevated factor VIII and von Willebrand factor levels predict unfavorable outcome in stroke patients treated with intravenous thrombolysis. Front Neurol. 2018;8:721. https://doi.org/10.3389/fneur.2017.00721
  30. De Meyer SF, Stoll G, Wagner DD, Kleinschnitz C. von Willebrand factor an emerging target in stroke therapy. Stroke. 2012;43(2):599-606. https://doi.org/10.1161/STROKEAHA.111.628867

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.